What's all the buzz about?
08/20/24 • 32 min
In a world of emerging and eradicated pathogens, how has Malaria remained such a successful infection? Since its earliest description as "bad air", this mosquito-driven hazard has remained lethal in some populations and regions. This episode addresses significant updates in its epidemiology, tips on diagnostics, some commentary on the vaccine and a lot more.
About our Guest:
Dr. Jaishree Raman is a molecular biologist by training with a strong interest in malaria and public health. Jaishree currently heads the Laboratory for Antimalarial Resistance Monitoring and Malaria Operational Research (ARMMOR) at the NICD. The core focus of ARMMOR is to improve malaria diagnostic and treatment options and to assist South Africa and Africa eliminate malaria. To this end, ARMMOR hosts the South African National Surveillance Programme for Antimalarial Drug and Diagnostic Resistance Monitoring. As the chair of the case management sub-committee of the South African Malaria Elimination Committee, Jaishree has developed and delivered training courses aimed at capacitating the malaria programme staff on case management protocols and practices. She is a member of several regional networks, such as the Elimination 8 and Pathogen Diversity Network Africa, that are aiming to strengthen malaria genomic and bioinformatics capacity across Africa. She co-developed a leadership and management course for malaria elimination targeting malaria programme staff currently being delivered by GIBBS and the University of Pretoria and is also a mentor on the recently launched Pan-African Malaria Control Association (PAMCA) LiftHerUp initiative, which is focussing on increasing African women leaders in science, with a major focus on vector-borne diseases.
Some resources from this episode:
- R21/Matrix-M vaccine: Phase 3 trial https://pubmed.ncbi.nlm.nih.gov/38310910/
- RTS,S/AS01 malaria vaccine: first results https://pubmed.ncbi.nlm.nih.gov/22007715/
- RTS,S/AS01 malaria vaccine: final results https://doi.org/10.1016/S0140-6736(15)60721-8
WE'D LOVE YOUR FEEDBACK ON THIS EPISODE –
Visit the Microbe Mail website to sign up for updates
Follow on:
Instagram: Microbe_Mail
X/Twitter: @microbemail
Facebook: MicrobeMail
Tiktok: @microbe.mail
Watch this episode on our new YouTube channel: Microbe Mail
E-mail us: [email protected]
In a world of emerging and eradicated pathogens, how has Malaria remained such a successful infection? Since its earliest description as "bad air", this mosquito-driven hazard has remained lethal in some populations and regions. This episode addresses significant updates in its epidemiology, tips on diagnostics, some commentary on the vaccine and a lot more.
About our Guest:
Dr. Jaishree Raman is a molecular biologist by training with a strong interest in malaria and public health. Jaishree currently heads the Laboratory for Antimalarial Resistance Monitoring and Malaria Operational Research (ARMMOR) at the NICD. The core focus of ARMMOR is to improve malaria diagnostic and treatment options and to assist South Africa and Africa eliminate malaria. To this end, ARMMOR hosts the South African National Surveillance Programme for Antimalarial Drug and Diagnostic Resistance Monitoring. As the chair of the case management sub-committee of the South African Malaria Elimination Committee, Jaishree has developed and delivered training courses aimed at capacitating the malaria programme staff on case management protocols and practices. She is a member of several regional networks, such as the Elimination 8 and Pathogen Diversity Network Africa, that are aiming to strengthen malaria genomic and bioinformatics capacity across Africa. She co-developed a leadership and management course for malaria elimination targeting malaria programme staff currently being delivered by GIBBS and the University of Pretoria and is also a mentor on the recently launched Pan-African Malaria Control Association (PAMCA) LiftHerUp initiative, which is focussing on increasing African women leaders in science, with a major focus on vector-borne diseases.
Some resources from this episode:
- R21/Matrix-M vaccine: Phase 3 trial https://pubmed.ncbi.nlm.nih.gov/38310910/
- RTS,S/AS01 malaria vaccine: first results https://pubmed.ncbi.nlm.nih.gov/22007715/
- RTS,S/AS01 malaria vaccine: final results https://doi.org/10.1016/S0140-6736(15)60721-8
WE'D LOVE YOUR FEEDBACK ON THIS EPISODE –
Visit the Microbe Mail website to sign up for updates
Follow on:
Instagram: Microbe_Mail
X/Twitter: @microbemail
Facebook: MicrobeMail
Tiktok: @microbe.mail
Watch this episode on our new YouTube channel: Microbe Mail
E-mail us: [email protected]
Previous Episode
Findings from FIDSSA 2024: Part 2
Earlier this year, some of the Microbe messengers attended the 10th FIDSSA Congress held in Johannesburg, South Africa. Besides being presenters themselves, they met and interviewed medical researchers in various infectious disease related fields.
This joint biennial congress hosted by the Federation of Infectious Diseases Societies of Southern Africa (FIDSSA) brings together healthcare professionals from its various societies, where members share research experiences and outcomes.
Let's hope this acts as a catalyst for collaborative work, culminating in comprehensive guidance in the management of infectious diseases.
To learn more about FIDSSA and its member societies visit: https://www.fidssa.co.za/
This episode includes discussions with:
- Professor David Lewis
- Professor Robin Patel
- Professor Lucille Blumberg
- Professor Angela Dramowski
- Dr Tholang Khumalo
- Professor Eric Decloedt
Some resources from this episode:
- Southern African HIV Clinicians Society 2022 guideline for the management of sexually transmitted infections: Moving towards best practice: http://dx.doi.org/10.4102/sajhivmed.v23i1.1450
- Tanapox, South Africa: https://pubmed.ncbi.nlm.nih.gov/37022936/
- NEISSERIA GONORRHOEAE ANTIMICROBIAL RESISTANCE SURVEILLANCE IN GAUTENG PROVINCE, SOUTH AFRICA
WE'D LOVE YOUR FEEDBACK ON THIS EPISODE –
Visit the Microbe Mail website to sign up for updates
Follow on:
Instagram: Microbe_Mail
X/Twitter: @microbemail
Facebook: MicrobeMail
Tiktok: @microbe.mail
Watch this episode on our new YouTube channel: Microbe Mail
E-mail us: [email protected]
Next Episode
3rd anniversary special episode- Meet the messengers
Microbe mail turns 3 on the 14th of September, and we wanted to keep things light for this time of the year. In this special episode we flip the script, literally, and swop our usual expert interviews for some team banter as Esther grills the team over a bunsen burner. We promise it’s more fun than a Petri dish!
WE'D LOVE YOUR FEEDBACK ON THIS EPISODE –
Visit the Microbe Mail website to sign up for updates
Follow on:
Instagram: Microbe_Mail
X/Twitter: @microbemail
Facebook: MicrobeMail
Tiktok: @microbe.mail
Watch this episode on our new YouTube channel: Microbe Mail
E-mail us: [email protected]
If you like this episode you’ll love
Episode Comments
Featured in these lists
Generate a badge
Get a badge for your website that links back to this episode
<a href="https://goodpods.com/podcasts/microbe-mail-264842/whats-all-the-buzz-about-70510817"> <img src="https://storage.googleapis.com/goodpods-images-bucket/badges/generic-badge-1.svg" alt="listen to what's all the buzz about? on goodpods" style="width: 225px" /> </a>
Copy